HIKMA PHARMA GMBH

Italy

All drugs from this manufacturer

  • BORTEZOMIB HIKMA

    It is used for the treatment of multiple myeloma (a type of bone marrow cancer) in adult patients and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in adult patients.

    Dosage form: powder for solution for injection

    Active substance Dosage
    bortezomib -

    ATC: L01XG01